JPS624401B2 - - Google Patents
Info
- Publication number
- JPS624401B2 JPS624401B2 JP2644577A JP2644577A JPS624401B2 JP S624401 B2 JPS624401 B2 JP S624401B2 JP 2644577 A JP2644577 A JP 2644577A JP 2644577 A JP2644577 A JP 2644577A JP S624401 B2 JPS624401 B2 JP S624401B2
- Authority
- JP
- Japan
- Prior art keywords
- pec
- dextran
- content
- partially substituted
- aqueous solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920002307 Dextran Polymers 0.000 claims description 10
- 125000000129 anionic group Chemical group 0.000 claims description 10
- 229960002086 dextran Drugs 0.000 claims description 10
- 229920001661 Chitosan Polymers 0.000 claims description 9
- 108010010803 Gelatin Proteins 0.000 claims description 8
- 125000002091 cationic group Chemical group 0.000 claims description 8
- 229920000159 gelatin Polymers 0.000 claims description 8
- 239000008273 gelatin Substances 0.000 claims description 8
- 235000019322 gelatine Nutrition 0.000 claims description 8
- 235000011852 gelatine desserts Nutrition 0.000 claims description 8
- 150000004676 glycans Chemical class 0.000 claims description 8
- 229920001282 polysaccharide Polymers 0.000 claims description 8
- 239000005017 polysaccharide Substances 0.000 claims description 8
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 239000005518 polymer electrolyte Substances 0.000 claims description 5
- 229920002491 Diethylaminoethyl-dextran Polymers 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 229960000633 dextran sulfate Drugs 0.000 claims description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 22
- 239000007864 aqueous solution Substances 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- 239000008186 active pharmaceutical agent Substances 0.000 description 10
- 239000000463 material Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical group CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000002429 anti-coagulating effect Effects 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000002947 procoagulating effect Effects 0.000 description 3
- 238000006467 substitution reaction Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 229940030225 antihemorrhagics Drugs 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000002874 hemostatic agent Substances 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 239000003014 ion exchange membrane Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 239000003805 procoagulant Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2644577A JPS53110693A (en) | 1977-03-10 | 1977-03-10 | Process for producing polyelectrolyte complex |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2644577A JPS53110693A (en) | 1977-03-10 | 1977-03-10 | Process for producing polyelectrolyte complex |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS53110693A JPS53110693A (en) | 1978-09-27 |
| JPS624401B2 true JPS624401B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1987-01-30 |
Family
ID=12193696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2644577A Granted JPS53110693A (en) | 1977-03-10 | 1977-03-10 | Process for producing polyelectrolyte complex |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS53110693A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0661240B2 (ja) * | 1989-01-21 | 1994-08-17 | 新田ゼラチン株式会社 | ハム・ソーセージ類およびその製法 |
| US6200595B1 (en) | 1998-04-24 | 2001-03-13 | Kuraray Co., Ltd. | Medical adhesive |
| EP1962920A4 (en) * | 2005-12-01 | 2012-03-21 | Agency Science Tech & Res | THREE-DIMENSIONAL RECONSTITUTED EXTRACELLULAR MATRICES AS FURNITURE FOR TISSUE TECHNOLOGY |
| JP2009256672A (ja) * | 2008-03-28 | 2009-11-05 | Tottori Univ | Ｃｍｄを用いたキトサン微粒子の作製方法 |
-
1977
- 1977-03-10 JP JP2644577A patent/JPS53110693A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS53110693A (en) | 1978-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4301067A (en) | Chitin containing poly-ion complex | |
| EP0053473B1 (en) | Cellulose sulfate salt having anti-coagulating action and process for preparing same | |
| CN105622780B (zh) | 一种季铵化甲壳素的均相制备方法 | |
| US4882060A (en) | Dialysis membranes with improved compatibility | |
| US20030055211A1 (en) | Chitosan condensation products, their preparation and their uses | |
| JPS60203265A (ja) | 抗血液凝固性高分子材料 | |
| JPS624401B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| DE4123000A1 (de) | Verfahren zur herstellung von staerkeestern fuer klinische, insbesondere parenterale anwendung | |
| Fukuda et al. | In vitro clot formation on the polyelectrolyte complexes of sodium dextran sulfate with chitosan | |
| US3324109A (en) | Preparation of a degraded pectin | |
| JP2004002586A (ja) | 多糖類複合体及びその製造方法 | |
| JP2555418B2 (ja) | 多糖類組成物 | |
| US5132415A (en) | Method of manufacturing deoxycellulose compounds | |
| CN110845640B (zh) | 一种类肝素物质磺化柠檬酸改性壳聚糖及其制备方法 | |
| CN113430822A (zh) | 一种新型改性纤维素面膜基布的制备方法 | |
| CN115197449A (zh) | Fe3+-儿茶酚修饰季铵盐壳聚糖-氧化羧甲基纤维素双交联水凝胶的制备方法及其应用 | |
| JPS624043B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| WO1997017377A1 (en) | Process for making crystalline iron dextran | |
| JPS624044B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| SU1504237A1 (ru) | Способ получени пленок хитозана | |
| JPH01113431A (ja) | 高分子電解質複合体の製造法 | |
| CA1045126A (en) | Water soluble polymer esters and process for producing same | |
| JPH01113432A (ja) | 高分子電解質複合体の製造法 | |
| JPS621732B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| KR100284713B1 (ko) | 고분자음이온과단백질이결합된단백질복합체및그의제조방법 |